Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADT and Localized Radiotherapy in Oligometastatic Hormone-Sensitive Prostate Cancer
NCT00544830Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Aug 2006
- Primary completion
- Mar 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of goserelin, leuprolide, bicalutamide in prostate cancer (PCa), sponsored by City of Hope. Started Aug 2006; status: active, not recruiting.
02
Drugs
goserelinleuprolidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00544830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544830.